Depression and Its Associated Factor Among Women Using Hormonal Contraceptives: A Cross-Sectional Study in Jimma Town Public Health Facilities, Southwest Ethiopia, 2022

This study has shown that the prevalence of depression among contraceptive users was 38.8%. The age-group of 18-25 years, poor social support, an uncomfortable marital relationship, use of injectable hormonal contraceptives, and a BMI status >25 kg/m² have an impact on the prevalence of depression. Based on these findings, it is recommended that women's health initiatives prioritize mental health services. Providing adequate mental health support and counseling can help address the prevalence of depression among contraceptive users. It is also suggested that health care providers carefully evaluate the risks and benefits for women before initiating hormonal contraception. It is important to provide special support to women who have poor social support, conflicts with their husbands, are overweight or obese, and are in their early twenties. To build on this knowledge, further prospective studies are suggested to explore the relationship between hormonal contraception and depression.